2017 Volume 11 Issue 12 Pages 608-614
Objective: N-butyl cyanoacrylate (NBCA) is used as a liquid embolic agent in various hemorrhagic situations with a high technical success rate and low recurrent bleeding rate, especially in patients with coagulopathy.
Case Presentation: An adult patient was admitted to the intensive care unit with coagulopathy and hemorrhagic shock. Past medical history of the patient included dual-antiplatelet therapy and warfarinization for several cardiac diseases. Retroperitoneal hematoma caused by femoral artery (FA) branch injury following percutaneous FA puncture was determined. Thus, we performed endovascular therapy (EVT) using NBCA and achieved successful hemostasis.
Conclusion: NBCA used for hemostasis is linked to good technical success and the absence of complications. We concluded that EVT using NBCA is safe and effective among patients with iatrogenic FA branch injury following neuro endovascular therapy as adjunct for other conventional embolic agents.
